Trials / Completed

CompletedNCT00002039

An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients

Status: Completed
Phase: N/A
Study type: Interventional
Enrollment: —

Sponsor: Astra USA · Industry
Sex: All
Age: 18 Years – 65 Years
Healthy volunteers: Not accepted

Summary

To evaluate the safety and efficacy of foscarnet induction therapy for treatment of AIDS patients experiencing their first episode of cytomegalovirus (CMV) retinitis. To evaluate the safety and efficacy of three different foscarnet maintenance therapy regimens. To determine the pharmacokinetics of intermittent administration of foscarnet with or without concomitant administration of zidovudine (AZT).

Conditions

Cytomegalovirus Retinitis
HIV Infections

Interventions

Type	Name	Description
DRUG	Foscarnet sodium

Timeline

First posted: 2001-08-31
Last updated: 2005-06-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00002039. Inclusion in this directory is not an endorsement.